Poster presented at WCLC 2022 investigating the effectiveness of PD-1 inhibition as compared to chemotherapy in previously treated advanced non-small cell lung cancer (NSCLC).

Poster presented at WCLC 2022 investigating the potential for using a selective kinase inhibitor in combination with a PD-1 inhibitor, in patients with PD-L1 positive, locally advanced or metastatic, squamous non-small cell lung cancer (NSCLC).

Poster presented at WCLC 2022 investigating the potential for using a selective kinase inhibitor in combination with a PD-1 inhibitor, in patients with PD-L1 positive, locally advanced or metastatic, squamous non-small cell lung cancer (NSCLC).

Poster presented at WCLC 2022 investigating the potential for using combination immunotherapy, a PD-1 inhibitor and a TIGIT inhibitor, in patients with metastatic non-small cell lung cancer (NSCLC).